Clarus Therapeutics Hldgs Inc (CRXT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0475 -0.0215 (-31.16%) 09/06/22 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0475 unch (unch) -
for Tue, Sep 6th, 2022
Results
download Want to compare other data? Select Fields| Symbol | CRXT | INM | QLGN | ||
| Company | Clarus Therapeutics Hldgs Inc | Inmed Pharmaceuticals Inc | Qualigen Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0650 | 2.15 | 3.23 | ||
| High | 0.0749 | 2.45 | 3.23 | ||
| Low | 0.0475 | 2.13 | 2.99 | ||
| Last | 0.0475 | 2.42 | 3.17 | ||
| Change | -0.0215 | +0.17 | +0.17 | ||
| % Change | -31.16% | +7.78% | +5.62% | ||
| Volume | 2,737,100 | 44,700 | 27,600 | ||
| 20-Day Average Volume | 4,348,840 | 24,895 | 120,355 | ||
| Previous Close | 0.0690 | 2.25 | 3.00 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2088 | 2.47 | 3.29 | ||
| 20-Day Raw Stochastic | 0.00% | 59.75% | 17.34% | ||
| 20-Day Relative Strength | 26.48% | 43.89% | 45.41% | ||
| Weighted Alpha | -96.72 | -80.27 | -83.15 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -69.75% since 08/29/22 | +16.59% since 04/02/25 | -7.08% since 04/02/25 | ||
| Low | 0.0475 on 09/06/22 | 1.72 on 04/07/25 | 2.99 on 04/09/25 | ||
| High | 0.1400 on 08/30/22 | 2.45 on 04/09/25 | 3.40 on 04/03/25 | ||
| 1-Month | |||||
| %Chg | -84.34% since 08/05/22 | -11.17% since 03/07/25 | +1.56% since 03/07/25 | ||
| Low | 0.0475 on 09/06/22 | 1.72 on 04/07/25 | 2.96 on 03/11/25 | ||
| High | 0.3489 on 08/15/22 | 2.90 on 03/17/25 | 4.02 on 03/28/25 | ||
| 3-Month | |||||
| %Chg | -90.08% since 06/06/22 | -46.23% since 01/08/25 | -24.01% since 01/08/25 | ||
| Low | 0.0475 on 09/06/22 | 1.72 on 04/07/25 | 2.96 on 03/11/25 | ||
| High | 0.4659 on 06/07/22 | 8.27 on 01/21/25 | 4.58 on 01/24/25 | ||
| 6-Month | |||||
| %Chg | -93.21% since 03/04/22 | -41.00% since 10/09/24 | -60.39% since 10/09/24 | ||
| Low | 0.0475 on 09/06/22 | 1.72 on 04/07/25 | 2.96 on 03/11/25 | ||
| High | 3.9400 on 04/20/22 | 8.27 on 01/21/25 | 10.45 on 10/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,471 | 2,716 | 2,209 | ||
| Shares Outstanding, K | 52,021 | 1,207 | 736 | ||
| Annual Sales | 13,960,000 | 4,600,000 | 0 | ||
| Annual Net Income | -40,620,000 | -7,680,000 | -13,420,000 | ||
| Last Quarter Sales | 4,050,000 | 1,110,000 | 0 | ||
| Last Quarter Net Income | -10,690,000 | -2,580,000 | -1,790,000 | ||
| 60-Month Beta | 1.96 | 0.30 | 0.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/18/22 | -3.64 on 02/12/25 | -4.70 on 11/14/24 | ||
| Latest Earnings Date | 08/22/22 | 05/13/25 | 04/04/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||